Walden Biosciences takes in $51m Series A
Cambridge, Massachusetts-based Walden Biosciences Inc, a biotech company focused on treating kidney disease, has raised $51 million in Series A financing.
Cambridge, Massachusetts-based Walden Biosciences Inc, a biotech company focused on treating kidney disease, has raised $51 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination